The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBioquell Regulatory News (BQE)

  • There is currently no data for BQE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) Bioquell Plc

20 Dec 2018 10:29

RNS Number : 1244L
Nplus1 Singer Capital Markets Ltd
20 December 2018
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Bioquell Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Bioquell Plc

(d) Date dealing undertaken:

19 December 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

If YES, specify which:

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

Ord 10p

 

 

Sale

 

2200

 

580p

 

580p

 

Ord 10p

 

 

Purchase

 

2027

 

579.1p

 

579.1p

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

20 December 2018

Contact name:

Damian Fernandez

Telephone number:

020 7496 3094

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERTMBMTMBTTBRP
Date   Source Headline
5th Oct 20158:43 amRNSDirector Declaration
26th Aug 20157:00 amRNSHalf Yearly Report
19th Aug 201510:25 amRNSForm 8.3 - Bioquell Plc
18th Aug 201510:27 amRNSForm 8.3 - Bioquell Plc
23rd Jul 20159:24 amRNSForm 8.3 - Bioquell Plc
10th Jul 20157:00 amRNSTrading Statement
6th Jul 20158:45 amRNSForm 8.3 - BIOQUELL plc
15th Jun 20151:56 pmRNSForm 8.3 - Bioquell PLC
1st Jun 201510:08 amRNSForm 8.3 - Bioquell Plc
29th May 20154:41 pmRNSForm 8.3 - Bioquell PLC
29th May 20151:17 pmRNSForm 8.3 - Bioquell Plc
28th May 20151:18 pmRNSForm 8.3 - Bioquell Plc
27th May 20151:02 pmRNSForm 8.3 - Bioquell Plc
27th May 201510:42 amRNSForm 8.3 - Andrew Muir
26th May 201510:22 amRNSForm 8.3 - [Bioquell Plc]
26th May 20158:41 amRNSForm 8 (OPD) (Amended - Bioquell PLC)
26th May 20157:00 amRNSForm 8.3 - Bioquell Plc
22nd May 20157:47 amRNSForm 8 (OPD) Bioquell PLC
21st May 201510:28 amRNSForm 8.3 - Bioquell Plc
20th May 20151:48 pmRNSForm 8.3 - Bioquell Plc
18th May 20154:09 pmRNSResult of AGM
18th May 201512:01 pmRNSForm 8.3 - Bioquell PLC
18th May 201511:30 amPRNForm 8.3 - Bioquell Plc
18th May 201510:48 amRNSForm 8.3 - Bioquell Plc
18th May 20157:00 amRNSStatement re AGM & Commencement of offer period
7th May 20153:11 pmRNSFurther re Disposal
7th May 20158:53 amRNSBlocklisting Interim Review
5th May 20153:18 pmRNSResult of EGM
5th May 20158:58 amRNSBlock Listing Application
17th Apr 20154:11 pmRNSNotice of EGM
15th Apr 20158:57 amRNSAnnual Financial Report
26th Mar 20159:57 amRNSDirector/PDMR Shareholding
18th Mar 20157:00 amRNSAnnual Financial Report
12th Mar 20157:00 amRNSProposed disposal of TRaC Global Limited
15th Jan 20157:00 amRNSPre Close Update
6th Jan 20159:12 amRNSDirector Declaration
27th Nov 201411:44 amRNSDirector/PDMR Shareholding
27th Nov 201411:41 amRNSHolding(s) in Company
26th Nov 201412:58 pmRNSDirector/PDMR Shareholding
19th Nov 20147:00 amRNSInterim Management Statement
7th Nov 20148:19 amRNSBlocklisting Interim Review
24th Oct 201410:40 amRNSDirector/PDMR Shareholding
2nd Sep 201412:07 pmRNSDirector/PDMR Shareholding
26th Aug 20147:00 amRNSHalf Yearly Report
19th May 20144:02 pmRNSResult of AGM
15th May 20147:00 amRNSInterim Management Statement
8th May 20144:50 pmRNSHolding(s) in Company
6th May 20142:05 pmRNSBlocklisting Interim Review
23rd Apr 20145:06 pmRNSHolding(s) in Company
14th Apr 20144:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.